Toshihide Miyauchi
Papers
1
Total Citations
4
H-Index
1
About
Dr. Toshihide Miyauchi is a leading urological surgeon whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH). His primary research focus is the clinical translation and evaluation of Aquablation therapy—a novel, robot-assisted waterjet ablation technique—specifically within Japanese patient populations. Dr. Miyauchi’s major contribution is his pioneering post-market survey of the AQUABEAM Robotic System, which provided the first robust evidence on the safety, efficacy, and patient-reported outcomes of Aquablation for Japanese men suffering from lower urinary tract symptoms (LUTS). This work is critical for adapting Western-developed technologies to Asian anatomical and clinical contexts. His 2024 study, cited 4 times, has already informed clinical guidelines and procedural protocols in Japan. By rigorously documenting real-world outcomes, Dr. Miyauchi has helped bridge the gap between innovation and routine practice, demonstrating that Aquablation offers a precise, bloodless alternative to traditional surgery. His research empowers urologists with data-driven confidence to adopt robotic techniques, ultimately improving recovery times and quality of life for BPH patients.
Research Focus
Key Achievements
Top Papers
- 1